US Patent Issued to The Third Clinical Medical College, Nanjing University of Chinese Medicine on Feb. 11 for "Magnetic nano-drug with double targeting VEGF-VEGFR, and preparation method and application thereof" (Chinese Inventors)

ALEXANDRIA, Va., Feb. 12 -- United States Patent no. 12,220,413, issued on Feb. 11, was assigned to The Third Clinical Medical College, Nanjing University of Chinese Medicine (Nanjing, China).

"Magnetic nano-drug with double targeting VEGF-VEGFR, and preparation method and application thereof" was invented by Xin Liu (Nanjing, China), Ran Kang (Nanjing, China), Lin Xie (Nanjing, China), Congyang Xue (Nanjing, China), Bo Chen (Nanjing, China), Zihan Wang (Nanjing, China), Nan Wang (Nanjing, China) and Liping Chen (Nanjing, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides a magnetic nano-drug with double targeting vascular endothelial growth factor (VEGF)-vascular endothelia...